Insights into cultivation strategies, bioactive components, therapeutic potential, patents, and market products of Ophiocordyceps sinensis: A comprehensive review.

Ophiocordyceps sinensis (Berk.), a Himalayan bioresource, has garnered considerable scientific and industrial interest due to the presence of numerous bioactive metabolites and extensive biological activities. However, O. sinensis demand and supply are extremely dependent on natural populations, raising conservation concerns. In the preceding years, numerous biotechnological interventions have been adopted for the artificial cultivation of O. sinensis to develop alternative and sustainable methods for reducing the stress on its natural populations; however, the cultivation of O. sinensis is limited. Literature exploration revealed that H. sinensis and other associated fungi have been utilized to cope with the increased O. sinensis demand. Additionally, O. sinensis culture-based products are being extensively used in various therapeutics and dietary supplements. Thus, the present article offers comprehensive insights into the current literature, research gaps, and future prospects on cultivation techniques with enriched bioactive metabolites for developing potential quality products of O. sinensis. In addition, a catalog of commercially available O. sinensis mycelial products is provided. Besides, we are highlighting the nutritional potential of O. sinensis with emphasis on patent search, available market products, and their labeling for end users. During the product assessment, a non-uniformity of the product labeling is observed as far as the bioactive components are concerned. Thus, it emerged as a major challenge and responsibility for manufacturers to produce high-quality products to meet the expectations of consumers. Keeping in view the demand, the nutraceutical industry must implement policies, regulations, and proper tactics of promotion and production for delivering apt nutrition and health benefits. [Display omitted] • Heavy metals accumulation in wild OS encourages cultured market products. • Non-invasive production methods can be employed for metabolite enhancement. • Majority of market products are devoid of active ingredients. • Bioactive metabolites, bioavailability, and authenticity must be prime requisites. [ABSTRACT FROM AUTHOR]